To finance the acquisition of a manufacturer of implants for spine surgery, Implanet has signed for the fourth time a convertible bond line with its long-term financial partner, Nice & Green
Amoéba, one of the major players in French biotech, renews for the third time a financing line of up to 23 million euros with Nice & Green to support its development
Facephi, a world leader in biometric solutions for identity verification, renews its contract with Nice & Green and obtains funding for 20 million euros to enhance its growth plan
Evolva, the Swiss biotech company, researching, developing and commercializing nature-based ingredients, has renewed its trust in Nice & Green by securing another CHF 12 million investment
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy
